|
[Related PubMed/MEDLINE] Total Number of Papers: 24
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: sIL-6R |
Long Form |
: soluble form of IL-6R |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
Interleukin-6: A Masterplayer in the Cytokine Network. |
IL-6, iMCD |
2 |
2018 |
Physiological effects of modulating the interleukin-6 axis. |
IL-6R |
3 |
2017 |
Enhancing Interleukin-6 and Interleukin-11 receptor cleavage. |
IL-11R, IL-6R |
4 |
2016 |
Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation. |
--- |
5 |
2014 |
Interleukin-6 and its receptors: a highly regulated and dynamic system. |
gp130, IL-6, sgp130 |
6 |
2012 |
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. |
IL-6, IL-6R |
7 |
2011 |
The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. |
ADAM, IL-6, IL-6R, sgp130 |
8 |
2011 |
The structure of the unliganded extracellular domain of the interleukin-6 signal transducer gp130 in solution. |
IL-6, IL-6R, SAXS |
9 |
2008 |
IL-6/IL-6R axis plays a critical role in acute kidney injury. |
AKI, IL-6R |
10 |
2008 |
Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130. |
gp130, IL-6, sgp130 |
11 |
2007 |
Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. |
mIL-6R, OVA, STAT |
12 |
2007 |
Novel role of IL-6/SIL-6R signaling in the expression of inducible nitric oxide synthase (iNOS) in murine B16, metastatic melanoma clone F10.9, cells. |
iNOS, JNK, MAPK |
13 |
2007 |
The IL-6/sIL-6R complex as a novel target for therapeutic approaches. |
mIL-6R, CD126 |
14 |
2004 |
Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. |
gp130, IL, IL-6R, MAPK, MFH, PNS, STAT3 |
15 |
2003 |
Anti-interleukin-6 therapy for Crohn's disease. |
CD, IFN-gamma, IL-6, IL-6R, LP, mAb, TGF-beta, TNF-alpha |
16 |
2003 |
IL-6 and Crohn's disease. |
IL-6, mAb |
17 |
2001 |
Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. |
GFAP, IL-6, IL-6R, LIF, STAT3 |
18 |
2000 |
Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. |
CU, IL-6, IL-6R, PBMC, PMMA, UR |
19 |
1999 |
Disulfide bond structure and N-glycosylation sites of the extracellular domain of the human interleukin-6 receptor. |
FNIII, IL-6, IL-6R |
20 |
1999 |
Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts. |
GF, IL-6, IL-6R |
21 |
1998 |
Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor. |
IL-6, IL-6R, MM, PMA, TIMP |
22 |
1998 |
In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. |
IL-6R |
23 |
1998 |
Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. |
BBB, CNS |
24 |
1995 |
Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. |
APP, IL-6 |
|